Home LiteratureArticle Details
PMID: 688225 Published · ppublish English Journal Article

Establishment and characterization of three new continuous cell lines derived from human breast carcinomas.

Cancer research ·Vol. 38 ·No. 10 ·1978-10-00 ·Pages 3352-64

Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ, Joyce MJ

Abstract

Three continuous lines of mammary tumor cells (ZR-75-1, ZR-75-27, and ZR-75-30) have been established from malignant effusions of two women with breast cancer. Differentiated properties expressed by each cell line include: (a) epithelial morphology (by light and electron microscopy) resembling that of the parental tumors; (b) presence of receptors for estrogen and other steroid hormones; and (c) growth responsiveness to estrogen and/or progesterone. All three cell lines possess human karyotypes that differ from one another in modal chromosome number as well as in characteristic marker chromosomes. Two of the cultures (ZR-75-27 and ZR-75-30), although derived from the same patient, have stable differences in their karyotypes.

MeSH Terms
Breast Neoplasms/genetics,metabolism,pathology Caseins/biosynthesis Cell Division Cell Line Chromosome Aberrations Female Humans Kinetics Lactalbumin/biosynthesis Microscopy, Electron Neoplasms, Experimental/pathology Neoplasms, Hormone-Dependent/metabolism Receptors, Steroid Thymidine/metabolism
Chemicals
Caseins Receptors, Steroid Lactalbumin Thymidine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Engel L W
Young N A
Tralka T S
Lippman M E
O'Brien S J
Joyce M J
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
1978-10-00
Pages
3352-64
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com